|
General Information
|
|
|
Product
|
Androgen Receptor Peptide
|
|
Verified Applications
|
Immunodepletion, Immunocompetition
|
|
Peptide Description
|
Synthetic peptide corresponding to amino acids within region 550-600 on Human Androgen Receptor.
|
|
Physical Properties
|
|
|
Quantity
|
250 ug
|
|
Purification Method
|
Immobilized antigen affinity chromatography
|
|
Storage
|
-20°C for long term storage
|
|
Application Protocol
|
|
Competition/Depletion assay
|
Refer to competition assay protocol
|
|
Protein
|
|
Uniprot #
|
P10275
|
|
Subcellular Location
|
Cytoplasm, Nucleus
|
|
Expression
|
Isoform 2:
Mainly expressed in heart and skeletal muscle.=
Isoform 3:
Expressed in basal and stromal cells of the prostate (at protein level).
|
|
Structure
|
Belongs to the nuclear hormone receptor family. NR3 subfamily.
|
|
Alternative Nomenclature
|
AIS
ANDR_HUMAN
Androgen nuclear receptor variant 2
Androgen receptor (dihydrotestosterone receptor; testicular feminization; spinal and bulbar muscular atrophy; Kennedy disease)
Androgen receptor
androgen receptor splice variant 4b
AR
AR8
DHTR
Dihydrotestosterone receptor
HUMARA
HYSP1
KD
Kennedy disease (KD)
NR3C4
Nuclear receptor subfamily 3 group C member 4 (NR3C4)
SBMA
SMAX1
Spinal and bulbar muscular atrophy (SBMA)
Testicular Feminization (TFM)
TFM
|
|
|
|
Androgen Receptor Antibody
Androgen Receptor Antibody BIOTIN
Androgen Receptor Antibody FITC
Androgen Receptor Positive Control
